Cuddihy R M, Bahn R S
Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
J Clin Endocrinol Metab. 1996 Feb;81(2):847-9. doi: 10.1210/jcem.81.2.8636314.
The association between the human leukocyte antigen (HLA) serotype DR3 and Graves' disease (GD) in Caucasian populations is well known. However, an even stronger association has been reported recently, especially in the male population, between the closely linked HLA allele DQA10501 and GD. We postulated that the reported association between DQA10501 and GD may be a result of the linkage of this allele with DR3 and may not represent an independent association. Accordingly, we screened a population of North American Caucasians (n = 218), including patients with GD (n = 101, 32 males, 69 females) and individuals with documented normal thyroid function (n = 117, 51 males, 66 females), for the presence of the DQA10501 allele and those alleles corresponding to the DR3 serotype (DRB103). Screening was accomplished using sequence specific PCR. A significant association was documented in the total study population between DR3 positivity and GD (P = 0.0002), but not between DQA10501 positivity and GD (P = 0.06). After gender stratification, significant associations were found only in the female population (DR3, P = 0.0004; DQA10501, P = 0.012) and not in the male population (DR3, P = 1.0; DQA10501, P = 1.0). Additionally, in those DR3 negative female subjects (n = 100), there was no independent association between DQA10501 positivity (n = 26) and GD (p = 0.82). P-values were corrected, where appropriate, for gender stratification and/or the number of HLA alleles tested. In conclusion, our results demonstrate a lack of independent association between the presence of the HLA allele DQA1*0501 and GD. We suggest that the apparent association between this allele and GD in the female population may be the result of its' close linkage to DR3.
人类白细胞抗原(HLA)血清型DR3与白种人群中格雷夫斯病(GD)之间的关联是众所周知的。然而,最近有报道称,与DR3紧密连锁的HLA等位基因DQA10501与GD之间存在更强的关联,尤其是在男性人群中。我们推测,所报道的DQA10501与GD之间的关联可能是该等位基因与DR3连锁的结果,可能并不代表独立的关联。因此,我们对北美白种人群(n = 218)进行了筛查,其中包括GD患者(n = 101,男性32例,女性69例)和甲状腺功能记录正常的个体(n = 117,男性51例,女性66例),以检测DQA10501等位基因以及与DR3血清型(DRB103)相对应的那些等位基因的存在情况。筛查采用序列特异性PCR完成。在整个研究人群中,记录到DR3阳性与GD之间存在显著关联(P = 0.0002),但DQA10501阳性与GD之间不存在显著关联(P = 0.06)。按性别分层后,仅在女性人群中发现了显著关联(DR3,P = 0.0004;DQA10501,P = 0.012),而在男性人群中未发现显著关联(DR3,P = 1.0;DQA10501,P = 1.0)。此外,在那些DR3阴性的女性受试者(n = 100)中,DQA10501阳性(n = 26)与GD之间不存在独立关联(p = 0.82)。在适当情况下,对P值进行了性别分层和/或所检测的HLA等位基因数量的校正。总之,我们的结果表明HLA等位基因DQA1*0501的存在与GD之间缺乏独立关联。我们认为,该等位基因与女性人群中GD之间的明显关联可能是其与DR3紧密连锁的结果。